This is a preview of subscription content, log in via an institution to check access.
Notes
National Health Service
incremental cost-effectiveness ratios
Reference
Cortesi PA, et al. Management of Chronic Hepatitis C (Chc) Genotype 1 Treatment-Naive Patients in an Era of Rising Opportunities and Costs - a Cost-Effectiveness Analysis of Treatment Options. 49th Annual Meeting of the European Association for the Study of the Liver : abstr. P1215, 9 Apr 2014.
Rights and permissions
About this article
Cite this article
Patient selection key to cost effective hepatitis C treatment. PharmacoEcon Outcomes News 703, 6 (2014). https://doi.org/10.1007/s40274-014-1259-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1259-3